Amyris (AMRS) Stock Price, News & Analysis

Company Overview

Amyris, Inc. operates as a biotechnology company in Europe, North America, Asia, South America, and internationally. It creates, manufactures, and commercializes consumer products and ingredient, including clean beauty, personal care, and health and wellness consumer products; and ingredients to the flavor and fragrance, nutrition, food and beverage, and clean beauty and personal care end markets. The company markets its products under the Biossance, JVN, Rose Inc., Pipette, Costa Brazil, OLIKA, Purecane, Terasana, MenoLabs, EcoFabulous, Stripes, and 4U by Tia brand names. It has a collaboration and license agreement with the Infectious Disease Research Institute for the development of a COVID-19 vaccine. The company was formerly known as Amyris Biotechnologies, Inc. and changed its name to Amyris, Inc. in June 2010. Amyris, Inc. was incorporated in 2003 and is headquartered in Emeryville, California. On August 9, 2023, Amyris, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.05 to $1.17
• 52-Week Range: N/A
• Volume: 46.75 million shs
• Average Volume: 12.59 million shs
• Market Capitalization: $18.47 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AMRS Stock Analysis - Frequently Asked Questions

How were Amyris' earnings last quarter?

Amyris, Inc. (NASDAQ:AMRS) announced its quarterly earnings results on Monday, November, 8th. The biotechnology company reported ($0.11) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.15) by $0.04. The firm's revenue was up 39.7% compared to the same quarter last year.
Read the conference call transcript.

When did Amyris' stock split?

Amyris's stock reverse split on Tuesday, June 6th 2017.The 1-15 reverse split was announced on Tuesday, June 6th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Monday, June 5th 2017. An investor that had 100 shares of stock prior to the reverse split would have 7 shares after the split.

What other stocks do shareholders of Amyris own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Amyris investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), PayPal (PYPL), Tesla (TSLA) and

Company Calendar

• Last Earnings: 11/08/2021
• Today: 9/15/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Basic Materials
• Industry: Specialty Chemicals
• Sub-Industry: Oil & Gas Refining & Marketing
• Current Symbol: NASDAQ:AMRS
• CIK: 1365916
• Web: amyris.com
• Phone: (510) 450-0761
• Fax: 510-225-2645
• Employees: 1,598
• Year Founded: 2003

Profitability

• EPS (Trailing Twelve Months): ($1.93)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$528.51 million
• Net Margins: -229.12%
• Pretax Margin: -235.25%
• Return on Equity: N/A
• Return on Assets: -80.35%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.52
• Quick Ratio: 0.29

Sales & Book Value

• Annual Sales: $269.85 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($1.52) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 369,390,000
• Free Float: 235,299,000
• Market Cap: $18.47 million
• Optionable: Optionable
• Beta: 1.19